As a consequence of its
complex nature, the biotechnological industry represents a challenge
to entrepreneurs and investors. An appropriate understanding of
this field requires a large spectrum of specific assets:
Legitimacy through a substantial
understanding of scientific and technical aspects
Precise Intellectual Property
understanding
Effective communication skills to
market complex products and systems
The industry’s trust at the highest management level
through a proven path record
BDC combines these competences effectively. Its strength
is people: employees, partners and network. Together, its
executive members represent over 75 years of experience in the
international pharmaceutical and diagnostic businesses,
biotechnological industry, medical research and business. This
exceptional complementarity coupled with experience and rigor is the
reason BDC is chosen as a consultant by leading financial
institutions, pharma and biotech companies.
